ArticlePloS one2014

Promoter methylation-mediated silencing of β-catenin enhances invasiveness of non-small cell lung cancer and predicts adverse prognosis.

Yuan Miao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.